Page 364 - Multidisipliner Covid 19

BÖLÜM 22

Guidon A, et al. Guidance for the management of myasthenia gravis
(MG) and Lambert-Eaton myasthenic syndrome (LEMS). J Neurol Sci.
2020;412:116803.
43. Gautret P, Lagier J-C, Parola P, et al. Hydroxychloroquine and azithro-
mycin as a treatment of COVID-19: results of an open-label non-rand-
omized. Int J Antimicrob Agents. 2020; Mar 20:105949.
44. Xu X, Han M, Li T, et l. Effective Treatment of Severe COVID-19 Patients
With Tocilizumab. Proc Natl Acad Sci USA. 2020;117(20):10970-10975.
45. COVID-19 Associated Risks and Effects in Myasthenia Gravis (CARE-
MG) Registry. https://myasthenia.org/For-Professionals/Resources-
for-Professionals/ CARE-MG
46. Ottavianni D, Boso F, Tranquillini E, et al. Early Guillain-Barré syndrome
in coronavirus disease 2019 (COVID-19): a case report from an Italian
COVID-hospital. Neurol Sci. 2020; 41(6):1351-1354.
47. Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, et al. Miller Fisher Syn-
drome and polyneuritis cranialis in COVID-19. Neurology. 2020;Apr
17:10.1212/WNL. 0000000000009619.
48. Veerapandiyan A , Wagner KR, Apkon S, et al. The care of patients
with Duchenne, Becker, and other muscular dystrophies in the COVID-
19 pandemic. Muscle Nerve. 2020 Apr 24;10.1002/mus.26902
49. Solé G, Salort-Campana E, Pereon Y, et al. Guidance for the care of
neuromuscular patients during the COVID-19 pandemic outbreak
from the French Rare Health Care for Neuromuscular Diseases Network.
Rev Neurol (Paris). 2020;176(6):507-515.
50. Pazarlı C, Ekiz T, İlik F. Coronavirus disease 2019 and obstructive sleep
apnea syndrome. Sleep Breath. 2020 Apr 28:1
51. Manto M, Dupre N, Hadjivassiliou M, et al. Management of Patients
with Cerebellar Ataxia During the COVID-19 pandemic: Current Con-
cerns and Future Implications. Cerebellum. 2020;May 13;1-7.
52. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown
apparent efficacy in treatment of COVID-19 associated pneumonia in
clinical studies. Biosci Trends. 2020; 14(1): 72–73.
53. Brison E, Jacomy H, Desforges M, Talbot PJ. Novel treatment with neu-
roprotective and antiviral properties against a neuroinvasive human
respiratory virus. J Virol. 2014;88(3):1548-1563.
54. Tipton PW, Wszolek ZK. What can Parkinson’s disease teach us about
COVID-19? Neurol Neurochir Pol. 2020;54(2):204-206.

363